Clinical Trial

Modeling the Early Stages of Autoimmunity Through the Study of Immunological Thrombocytopenic Purpura and Juvenile Lupus

Study acronym: PRELUDE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Immunologic thrombocytopenic purpura (ITP) in children is a pre-lupus condition if associated with the presence of anti-nuclear antibodies (ANA), providing a unique model for understanding the natural history of autoimmunity, particularly that of systemic lupus erythematosus (SLE). The investigators will describe the shared and/or unique immunological pathways involved at diagnosis in 70 children with ITP and in 20 children with SLE, and compare them between ITP-ANA- (more often transient), ITP-ANA+ (pre-lupus condition, more often persistent) and SLE
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-06-25; most recent amendment 2026-07-15.
Trial Details
NCT Number NCT07680010
Lead Sponsor University Hospital, Bordeaux
Conditions Immune Thrombocytopenic Purpura ( ITP ), Systemic Lupus Erythematosus (SLE)
Enrollment 105 participants
Start Date 2026-07
Primary Completion 2029-10 (estimated)
Study Completion 2033-10 (estimated)
Updated on ClinicalTrials.gov 2026-07-17